Search results
Results from the WOW.Com Content Network
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (trade name: Fosun Pharma) is a Chinese pharmaceutical company.It is mostly owned by Fosun International. [2]As of 2018, the A shares of the company is a constituent of SSE 180 Index as well as its sub-index SSE MidCap Index. [3]
There's doubtlessly some coming uncertainty for both, but the prices are right.
Main Menu. Health. Health
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Eli Lilly wasn’t one of them. The 10 stocks that made the cut ...
This is a list of companies on the Shenzhen Stock Exchange up to 2011, along with their capital, industry, and listing date. Many of these are subsidiaries of state-owned enterprises. Many of these are subsidiaries of state-owned enterprises.
Chengdu Kanghong Pharmaceutical Group Co., Ltd. is a publicly traded pharmaceutical company based in the province of Sichuan, China. [1] It was founded in 1996 and researches, develops, manufactures, and distributes medicines [ 2 ] for ophthalmic , central nervous , digestive and endocrine systems. [ 1 ]
The parent company of Sinopharm Group was Sinopharm Industrial Investment, a 51–49 joint venture of state-owned enterprise China National Pharmaceutical Group and civilian-run enterprise Fosun Pharmaceutical. Its H shares were listed on the Hong Kong Stock Exchange in 2009, [2] with its IPO price of HK$16 per share.
Sino Biopharmaceutical Limited (SEHK: 1177|Hang Seng Index component) (simplified Chinese: 中国生物制药有限公司; traditional Chinese: 中國生物製藥有限公司), shortly Sino Biopharm, is a pharmaceutical conglomerate in China. The Company was listed on the Hong Kong Stock Exchange in 2000 and included in 2013 as a constituent ...